$BridgeBio Pharma (BBIO.US)$Reuters 28 mins ago Attruby™ (Acoramidis), a Near Complete Ttr Stabilizer (≥90%), Approved by FDA to Reduce Cardiovascular Death and Cardiovascular-Related Hospitalization in Attr-Cm Patients BridgeBio Pharma Inc - to Receive $500 Million Payment Under Royalty Agreement BridgeBio Pharma Inc - Grants Bayer Rights to Commercialize Acoramidis in Europe
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.